Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 11, 2026
TickeronGET DAILY SIGNALS
Marsh McLennan (MRSH) Q3 2026 Earnings Preview: What Analysts Are Watching

Marsh McLennan (MRSH) Q3 2026 Earnings Preview: What Analysts Are Watching

Key Takeaways

  • Marsh McLennan (MRSH) is scheduled to report third-quarter 2026 results on Thursday, October 15, 2026, before the market opens.
  • Analyst consensus points to earnings of roughly $1.96 per share, up about 6% from the prior-year quarter.
  • Consensus revenue is approximately $6.63 billion, an expected increase of about 4.5% year over year.
  • The company topped expectations in its most recent quarter, posting $2.96 per share versus a $2.88 estimate.
  • Investors will focus on organic growth, insurance pricing trends, and management's full-year guidance.

Why These Results Carry Weight

Marsh McLennan stands as one of the largest professional services firms globally, covering risk management, insurance broking, consulting, and workforce strategies. With clients spanning multinationals to mid-sized companies, its performance offers a useful window into corporate confidence and spending patterns. The firm has posted a consistent series of earnings beats, including the second quarter of 2026 when results came in above consensus. That history sets a high bar for the upcoming report, as investors seek signs that demand for risk advisory, insurance placement, and consulting services holds up amid economic uncertainty.

Consensus Estimates for the Quarter

Wall Street expects earnings per share of about $1.96 for the third quarter of 2026, representing a year-over-year rise of roughly 6%. Revenue is projected near $6.63 billion, up approximately 4.5% from the same period last year. These numbers reflect analyst estimates rather than company guidance and serve as a reference point.

In the previous quarter, MRSH reported EPS of $2.96 against a consensus of $2.88, with revenue climbing 6.2% year over year to $7.28 billion. Attention will turn to whether the company sustains that pace, especially within its Risk & Insurance Services segment, the larger and steadier contributor. Key areas to track include organic revenue growth, adjusted operating margins, and any updates on insurance pricing across property, casualty, and specialty lines. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Sentiment Heading Into the Report

Investor views on MRSH reflect its profile as a defensive, cash-generative business with a reliable history of beating estimates. That consistency has tended to limit post-earnings volatility relative to more cyclical sectors, yet the market still responds to surprises in growth, margins, or outlook. Potential concerns include any easing in insurance pricing, softer consulting demand, or currency effects that could pressure reported revenue. Even a solid earnings beat paired with cautious commentary on the call could lead to a measured reaction, highlighting the importance of management’s tone.

Items to Monitor After the Release

Following the report, focus will shift to the company’s organic growth path, which removes acquisition and currency impacts to reveal underlying demand trends. Strength in Risk & Insurance Services would point to healthy client spending on coverage and advisory services, while any slowdown might signal pricing pressure or reduced renewals.

Margin trends deserve attention as well. As a professional services provider, profitability hinges on cost control and efficiency, so remarks on compensation expenses, technology spending, and operating leverage will inform the full-year outlook.

Updates to 2026 guidance and any notes on capital allocation, including buybacks or dividends, will also matter. Broader industry factors such as property and casualty pricing cycles and consulting demand will help shape how the results are interpreted for future quarters.

Using AI Tools for Deeper Analysis

In my own review process, Tickeron’s AI-powered screening capabilities have proven useful for quickly comparing MRSH against peers and spotting technical or fundamental shifts in the insurance and professional services space. The platform lets users apply filters across industries, market caps, patterns, and performance metrics to surface relevant ideas more efficiently than manual methods. From what I see, this approach helps keep the focus on the metrics that matter most ahead of events like earnings releases.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MRSH

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MRSH in upward trend: 10-day moving average crossed above 50-day moving average on October 20, 2026

The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on MRSH as a result. In 46 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for MRSH just turned positive on October 02, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in 27 of 50 cases over the following month. The odds of a continued upward trend are 54%.

MRSH moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 161 of 338 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.

The Aroon Indicator entered an Uptrend today. In 100 of 271 cases where MRSH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 37%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.

MRSH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.306) is normal, around the industry mean (2.653). P/E Ratio (24.436) is within average values for comparable stocks, (18.087). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.020) settles around the average of (0.045) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (2.968).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 14.7B. The market cap for tickers in the group ranges from 3.03K to 95.74B. MRSH holds the highest valuation in this group at 95.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -1%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was 21%. SLQT experienced the highest price growth at 16%, while ZBAO experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was -0% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 70
Price Growth Rating: 51
SMR Rating: 70
Profit Risk Rating: 85
Seasonality Score: 4 (-100 ... +100)
View a ticker or compare two or three
MRSH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Industry
N/A
Address
1166 Avenue of the Americas
Phone
+1 212 345-5000
Employees
95000
Web
https://www.corporate.marsh.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
Marsh McLennan (MRSH) Q3 2026 Earnings Preview: What Analysts Are Watching